Business
GSK profit lifted by HIV, asthma drugs in boost to new CEO
Its adjusted earnings per share rises to 25.5 pence, higher than analysts’ expectations reported better-than-expected profit in the fourth…
Tag
Its adjusted earnings per share rises to 25.5 pence, higher than analysts’ expectations reported better-than-expected profit in the fourth…
The buyback comes after GSK saw earnings per share, excluding some items, at 23.2 pence in the fourth quarter GSK plans to buy back £2…
GSK agreed to buy US biotech IDRx for as much as US$1.15 billion to gain new cancer medicines. The UK drugmaker will pay US$1 billion…